To investigate the therapeutic potential and mechanisms of Laminaria japonica polysaccharide (LJP) in alleviating neuroinflammation, a significant factor in cerebral ischemia/reperfusion (I/R) injury.
Key Findings:
LJP reduced infarct volume and improved neurological function in tMCAO mice, measured by specific neurological scoring systems.
LJP suppressed microglial pro-inflammatory polarization and decreased levels of IL-1b, TNFα, and IL-6, indicating a robust anti-inflammatory effect.
Granulocyte colony-stimulating factor (Csf3) was identified as a potential mediator of LJP's effects, warranting further investigation.
Interpretation:
LJP mitigates acute neuroinflammation post-I/R, likely through suppression of Csf3, suggesting its potential as a novel treatment for ischemic stroke, with implications for clinical application.
Limitations:
The study primarily focused on animal models, limiting direct applicability to human conditions; further research is needed to address this gap.
Further research is needed to fully elucidate the mechanisms of LJP and its effects on other inflammatory pathways, including potential side effects.
Conclusion:
LJP shows promise as a phytotherapeutic agent for ischemic stroke by targeting Csf3-related neuroinflammatory mechanisms, highlighting the need for further studies to validate these findings in human trials.
